All About Multiple Sclerosis

More MS news articles for February 2003

Recommendations Concerning Methylprednisolone Shortage

February 5, 2003

As you may be aware, there is a shortage of methylprednisolone, the drug most commonly used to treat MS exacerbations. Details concerning the shortage can be found at the website of the American Society of Health-System Pharmacists:

The two manufacturers, Abbott and Pharmacia, do not expect the problem to be resolved for several weeks.

For those who are unable to obtain methylprednisolone, our Chief Medical Officer, Dr. Aaron Miller, is recommending dexamethasone as a substitute. Use the following information to help you determine the dosing regimen:

We will post information updates as they become available.

© 2003 The National Multiple Sclerosis Society